# Karman Holdings Inc.: financial statements, quarterly

KRMN · NYSE · CIK 2040127 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/krmn.md) · [Financials](/companies/krmn/financials.md) · [Filings](/companies/krmn/filings.md) · [Insiders](/companies/krmn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/krmn/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [83.0](/filings/0000950170-25-071463.md) | [85.0](/filings/0000950170-25-105378.md) | [86.0](/filings/0001193125-25-270338.md) | [91.2 d](/filings/0002040127-26-000014.md) | [100](/filings/0001193125-26-222116.md) | [115](/filings/0002040127-26-000024.md) | [122](/filings/0001193125-25-270338.md) | [134 d](/filings/0002040127-26-000014.md) | [151](/filings/0001193125-26-222116.md) | [182](/filings/0002040127-26-000024.md) |
| Cost of revenue | $m | [54.0](/filings/0000950170-25-071463.md) | [50.4](/filings/0000950170-25-105378.md) | [52.2](/filings/0001193125-25-270338.md) | [56.5 d](/filings/0002040127-26-000014.md) | [60.7](/filings/0001193125-26-222116.md) | [68.1](/filings/0002040127-26-000024.md) | [71.8](/filings/0001193125-25-270338.md) | [80.9 d](/filings/0002040127-26-000014.md) | [87.3](/filings/0001193125-26-222116.md) | [104](/filings/0002040127-26-000024.md) |
| Gross profit | $m | [29.0](/filings/0000950170-25-071463.md) | [34.6](/filings/0000950170-25-105378.md) | [33.8](/filings/0001193125-25-270338.md) | [34.7 d](/filings/0002040127-26-000014.md) | [39.5](/filings/0001193125-26-222116.md) | [47.0](/filings/0002040127-26-000024.md) | [49.9](/filings/0001193125-25-270338.md) | [53.6 d](/filings/0002040127-26-000014.md) | [63.9](/filings/0001193125-26-222116.md) | [78.2](/filings/0002040127-26-000024.md) |
| Operating income | $m | [13.5](/filings/0000950170-25-071463.md) | [18.3](/filings/0000950170-25-105378.md) | [17.4](/filings/0001193125-25-270338.md) | [14.4 d](/filings/0002040127-26-000014.md) | [10.0](/filings/0001193125-26-222116.md) | [20.1](/filings/0002040127-26-000024.md) | [21.8](/filings/0001193125-25-270338.md) | [21.1 d](/filings/0002040127-26-000014.md) | [21.5](/filings/0001193125-26-222116.md) | [34.8](/filings/0002040127-26-000024.md) |
| Interest expense | $m | [12.1](/filings/0000950170-25-071463.md) | [13.4](/filings/0000950170-25-105378.md) | [12.5](/filings/0001193125-25-270338.md) | [12.7 d](/filings/0002040127-26-000014.md) | [11.4](/filings/0001193125-26-222116.md) | [11.9](/filings/0002040127-26-000024.md) | [10.0](/filings/0001193125-25-270338.md) | [11.3 d](/filings/0002040127-26-000014.md) | [12.6](/filings/0001193125-26-222116.md) | [15.3](/filings/0002040127-26-000024.md) |
| Income tax | $m | [0.1](/filings/0000950170-25-071463.md) | [0.3](/filings/0000950170-25-105378.md) | [0.9](/filings/0001193125-25-270338.md) | [0.3 d](/filings/0002040127-26-000014.md) | [3.3](/filings/0001193125-26-222116.md) | [1.8](/filings/0002040127-26-000024.md) | [4.2](/filings/0001193125-25-270338.md) | [5.8 d](/filings/0002040127-26-000014.md) | [0.8](/filings/0001193125-26-222116.md) | [5.2](/filings/0002040127-26-000024.md) |
| Net income | $m | [2.1](/filings/0001193125-25-270338.md) | [4.6](/filings/0001193125-25-270338.md) | [4.3](/filings/0001193125-25-270338.md) | [1.7 d](/filings/0002040127-26-000014.md) | [(4.8)](/filings/0002040127-26-000024.md) | [6.8](/filings/0002040127-26-000024.md) | [7.6](/filings/0001193125-25-270338.md) | [7.7 d](/filings/0002040127-26-000014.md) | [7.8](/filings/0002040127-26-000024.md) | [14.0](/filings/0002040127-26-000024.md) |
| Diluted EPS | $ per share | [0.01](/filings/0000950170-25-071463.md) | [0.03](/filings/0000950170-25-105378.md) | [0.03](/filings/0001193125-25-270338.md) | not reported | [(0.04)](/filings/0001193125-26-222116.md) | [0.05](/filings/0002040127-26-000024.md) | [0.06](/filings/0001193125-25-270338.md) | not reported | [0.06](/filings/0001193125-26-222116.md) | [0.11](/filings/0002040127-26-000024.md) |
| Basic EPS | $ per share | [0.01](/filings/0000950170-25-071463.md) | [0.03](/filings/0000950170-25-105378.md) | [0.03](/filings/0001193125-25-270338.md) | not reported | [(0.04)](/filings/0001193125-26-222116.md) | [0.05](/filings/0002040127-26-000024.md) | [0.06](/filings/0001193125-25-270338.md) | not reported | [0.06](/filings/0001193125-26-222116.md) | [0.11](/filings/0002040127-26-000024.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [5.5](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [11.5](/filings/0002040127-26-000014.md) | [114](/filings/0000950170-25-071463.md) | [27.4](/filings/0000950170-25-105378.md) | [18.7](/filings/0001193125-25-270338.md) | [34.0](/filings/0002040127-26-000024.md) | [73.8](/filings/0001193125-26-222116.md) | [51.7](/filings/0002040127-26-000024.md) |
| Current assets | $m | not reported | [158](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [202](/filings/0002040127-26-000014.md) | [302](/filings/0000950170-25-071463.md) | [242](/filings/0000950170-25-105378.md) | [261](/filings/0001193125-25-270338.md) | [291](/filings/0002040127-26-000024.md) | [370](/filings/0001193125-26-222116.md) | [385](/filings/0002040127-26-000024.md) |
| Total assets | $m | not reported | [711](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [774](/filings/0002040127-26-000014.md) | [875](/filings/0000950170-25-071463.md) | [954](/filings/0000950170-25-105378.md) | [968](/filings/0001193125-25-270338.md) | [1,104](/filings/0002040127-26-000024.md) | [1,418](/filings/0001193125-26-222116.md) | [1,444](/filings/0002040127-26-000024.md) |
| Current liabilities | $m | not reported | [87.1](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [115](/filings/0002040127-26-000014.md) | [90.3](/filings/0000950170-25-071463.md) | [88.2](/filings/0000950170-25-105378.md) | [91.1](/filings/0001193125-25-270338.md) | [88.7](/filings/0002040127-26-000024.md) | [105](/filings/0001193125-26-222116.md) | [108](/filings/0002040127-26-000024.md) |
| Total liabilities | $m | not reported | [528](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [578](/filings/0002040127-26-000014.md) | [526](/filings/0000950170-25-071463.md) | [592](/filings/0000950170-25-105378.md) | [599](/filings/0001193125-25-270338.md) | [721](/filings/0002040127-26-000024.md) | [1,012](/filings/0001193125-26-222116.md) | [1,023](/filings/0002040127-26-000024.md) |
| Current portion of debt | $m | not reported | [6.3](/filings/0000950170-25-052639.md) | not reported | not reported | not reported | [7.1](/filings/0002040127-26-000014.md) | [7.1](/filings/0000950170-25-071463.md) | [2.8](/filings/0000950170-25-105378.md) | [2.8](/filings/0001193125-25-270338.md) | [3.8](/filings/0002040127-26-000024.md) | [5.6](/filings/0001193125-26-222116.md) | [5.6](/filings/0002040127-26-000024.md) |
| Shareholders' equity | $m | [178](/filings/0002040127-26-000014.md) | [182](/filings/0002040127-26-000014.md) | [185](/filings/0001193125-25-270338.md) | [190](/filings/0001193125-25-270338.md) | [194](/filings/0001193125-25-270338.md) | [196](/filings/0002040127-26-000024.md) | [349](/filings/0002040127-26-000024.md) | [361](/filings/0002040127-26-000024.md) | [369](/filings/0001193125-25-270338.md) | [383](/filings/0002040127-26-000024.md) | [406](/filings/0002040127-26-000024.md) | [421](/filings/0002040127-26-000024.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.1](/filings/0000950170-25-071463.md) | [6.1 d](/filings/0000950170-25-105378.md) | [9.9 d](/filings/0001193125-25-270338.md) | [7.6 d](/filings/0002040127-26-000014.md) | [(13.6)](/filings/0001193125-26-222116.md) | [(17.4) d](/filings/0002040127-26-000024.md) | [0.1 d](/filings/0001193125-25-270338.md) | [8.7 d](/filings/0002040127-26-000014.md) | [0.2](/filings/0001193125-26-222116.md) | [(3.2) d](/filings/0002040127-26-000024.md) |
| Capital expenditure | $m | [1.6](/filings/0000950170-25-071463.md) | [5.1 d](/filings/0000950170-25-105378.md) | [4.6 d](/filings/0001193125-25-270338.md) | [4.0 d](/filings/0002040127-26-000014.md) | [5.0](/filings/0001193125-26-222116.md) | [3.6 d](/filings/0002040127-26-000024.md) | [7.0 d](/filings/0001193125-25-270338.md) | [4.7 d](/filings/0002040127-26-000014.md) | [7.4](/filings/0001193125-26-222116.md) | [14.5 d](/filings/0002040127-26-000024.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [167](/filings/0000950170-25-071463.md) | [167](/filings/0000950170-25-105378.md) | [167](/filings/0001193125-25-270338.md) | [132](/filings/0001193125-26-222116.md) | [132](/filings/0002040127-26-000024.md) | [132](/filings/0001193125-25-270338.md) | [133](/filings/0001193125-26-222116.md) | [133](/filings/0002040127-26-000024.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 132,533,708 at 2026-08-03, from the cover of the [10-Q filed 2026-08-11](/filings/0002040127-26-000024.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.